ADRO Aduro Biotech, Inc.

11.80
+0.35  (3.06%)
Previous Close 11.45
Open 11.35
Price To book 3.07
Market Cap 792.75M
Shares 67,182,000
Volume 315,804
Short Ratio 27.54
Av. Daily Volume 253,087

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b primary endpoint not met - May 2016
CRS-207 and GVAX Pancreas - ECLIPSE trial
Pancreatic cancer
Partial clinical hold announced October 24, 2016. Hold released November 21, 2016.
CRS-207 and GVAX Pancreas and nivolumab - STELLAR trial
Pancreatic cancer
Phase 1/2 dosing initiated March 2016.Partial clinical hold announced October 24, 2016. Hold released November 21, 2016.
Epacadostat and CRS-207 - SEASCAPE
Ovarian cancer
Phase 2 trial to be initiated 1H 2017.
CRS-207
Mesothelioma - cancer

Latest News

  1. Aduro Biotech to Present at the Leerink Partners 6th Annual Global Healthcare Conference
  2. Aduro BioTech, Inc. breached its 50 day moving average in a Bullish Manner : ADRO-US : February 1, 2017
  3. Aduro Biotech Announces Appointment of Leading Immunotherapy and Oncology Experts to Scientific Advisory Board
  4. Aduro (ADRO) Inks License Agreement with Stanford University
  5. Aduro Biotech Enters into Exclusive License Agreement for Proprietary Neoantigen Identification Technology
  6. ETFs with exposure to Aduro BioTech, Inc. : January 17, 2017
  7. Aduro BioTech, Inc. breached its 50 day moving average in a Bullish Manner : ADRO-US : January 16, 2017
  8. Aduro BioTech, Inc. – Value Analysis (NASDAQ:ADRO) : January 9, 2017
  9. ADURO BIOTECH, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
  10. Aduro Biotech Announces Clinical Collaboration with Merck to Evaluate the Combination of Aduro’s CRS-207 with Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Gastric Cancer
  11. Aduro BioTech, Inc. breached its 50 day moving average in a Bullish Manner : ADRO-US : January 6, 2017
  12. Announcement from PT Adaro Energy Tbk - Ir Soebianto
  13. Currency Conversion Rate for 2016 Interim Dividend Payment
  14. Australia lobbies China-led AIIB to add coal to lending priorities
  15. Coal in Trump’s Stocking
  16. Energy thinktank cuts coal demand forecast for fifth year in row
  17. Clean Energy ‘Moving Forward’ Despite Trump’s E.P.A. Pick, Experts Say
  18. Aduro Biotech to Present at the 35th Annual J.P. Morgan Healthcare Conference
  19. 2016 Dividend Interim Payment Schedule and Procedure
  20. ADURO BIOTECH, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits